HUP2100370A1 - Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3 - Google Patents
Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3Info
- Publication number
- HUP2100370A1 HUP2100370A1 HU2100370A HUP2100370A HUP2100370A1 HU P2100370 A1 HUP2100370 A1 HU P2100370A1 HU 2100370 A HU2100370 A HU 2100370A HU P2100370 A HUP2100370 A HU P2100370A HU P2100370 A1 HUP2100370 A1 HU P2100370A1
- Authority
- HU
- Hungary
- Prior art keywords
- vitamin
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 title 2
- 229940021056 vitamin d3 Drugs 0.000 title 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2100370A HUP2100370A1 (en) | 2021-10-28 | 2021-10-28 | Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2100370A HUP2100370A1 (en) | 2021-10-28 | 2021-10-28 | Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP2100370A1 true HUP2100370A1 (en) | 2023-05-28 |
Family
ID=89993449
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU2100370A HUP2100370A1 (en) | 2021-10-28 | 2021-10-28 | Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3 |
Country Status (1)
Country | Link |
---|---|
HU (1) | HUP2100370A1 (en) |
-
2021
- 2021-10-28 HU HU2100370A patent/HUP2100370A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL275704A (en) | Oral pharmaceutical formulation comprising cannabinoids and poloxamer | |
EP4146198A4 (en) | Novel compositions of matter and pharmaceutical compositions | |
EP4149470A4 (en) | Pharmaceutical formulations and uses thereof | |
EP4183391A4 (en) | Pharmaceutical composition and use thereof | |
IL311331A (en) | Pharmaceutical composition and use thereof | |
EP4106870A4 (en) | Compositions and therapeutic uses of cannabidiol | |
EP4073071A4 (en) | Use and pharmaceutical composition of phenylisoxazolyl methylene-naphthalene-ether derivatives | |
EP3969054A4 (en) | Oil-soluble drug containing compositions and methods of use thereof | |
EP4103539A4 (en) | Compounds and pharmaceutical uses thereof | |
SG11202112487QA (en) | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | |
HUP2100370A1 (en) | Vitamin d3 and use of a pharmaceutical composition comprising vitamin d3 | |
GB202010230D0 (en) | Pharmaceutical formulation | |
EP3849532A4 (en) | Sustained-release pharmaceutical compositions comprising of a sedative drug and uses thereof | |
EP4180040A4 (en) | Pharmaceutical composition and application thereof | |
GB202217964D0 (en) | Pharmaceutical and cosmetic compositions comprising secretomes | |
IL297081A (en) | Pharmaceutical formulation | |
EP4129283A4 (en) | Pharmaceutical combination and use thereof | |
IL287912A (en) | Pharmaceutical composition of a weak acid drug and methods of administration | |
IL283320A (en) | Single-dose use of a composition comprising a particular mixture of grape extract and blueberry extract | |
EP4115902A4 (en) | Combined use of ctb006 and ponatinib | |
IL271875B (en) | Application of totarol and pharmaceutical composition containing totarol | |
ZA202109873B (en) | Application of pectolinarin in preparation of anti-osteosarcoma drugs | |
GB202316715D0 (en) | Medicinal products and uses thereof | |
EP4100020A4 (en) | Aspacytarabine pharmaceutical compositions and uses thereof | |
EP4129282A4 (en) | Pharmaceutical combination and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA9A | Lapse of provisional patent protection due to relinquishment or protection considered relinquished |